EVH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EVH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-18), Evolent Health's share price is $23.07. Evolent Health does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.
The historical rank and industry rank for Evolent Health's Price-to-Owner-Earnings or its related term are showing as below:
During the past 11 years, the highest Price-to-Owner-Earnings of Evolent Health was 466.79. The lowest was 0.00. And the median was 418.79.
As of today (2024-05-18), Evolent Health's share price is $23.07. Evolent Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.25. Therefore, Evolent Health's PE Ratio for today is At Loss.
As of today (2024-05-18), Evolent Health's share price is $23.07. Evolent Health's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.01. Therefore, Evolent Health's PE Ratio without NRI for today is At Loss.
During the past 11 years, Evolent Health's highest PE Ratio without NRI was 1088.79. The lowest was 0.00. And the median was 403.81.
The historical data trend for Evolent Health's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Price-to-Owner-Earnings | Get a 7-Day Free Trial | - | - | - | - | - |
Evolent Health Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Price-to-Owner-Earnings | Get a 7-Day Free Trial | - | - | - | - | - |
For the Health Information Services subindustry, Evolent Health's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Evolent Health's Price-to-Owner-Earnings falls into.
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Evolent Health's Price-to-Owner-Earnings for today is calculated as
Price-to-Owner-Earnings | = | Share Price | / | Owner Earnings per Share (TTM) |
= | 23.07 | / | -0.10 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health (NYSE:EVH) Price-to-Owner-Earnings Explanation
For how to get Owner Earnings per Share (TTM), please click.
Thank you for viewing the detailed overview of Evolent Health's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.
Seth Blackley | officer: President | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Daniel Joseph Mccarthy | officer: PRESIDENT | 800 N GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Emily Ann Rafferty | officer: Chief Operating Officer | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Toyin Ajayi | director | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Cheryl Scott | director | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Mary Bridget Duffy | director | C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126 |
Diane Holder | director | 800 GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Richard M Jelinek | director | 40 W 47TH STREET, FLOOR 33, NEW YORK NY 10035 |
Frank J Williams | director, officer: Chief Executive Officer | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
John Paul Johnson | officer: Chief Financial Officer | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Jonathan Weinberg | officer: General Counsel | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Steve Tutewohl | officer: Chief Operating Officer | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Tunde Sotunde | director | 800 N. GLEBE RD, SUITE 500, ARLINGTON VA 22203 |
Kim Keck | director | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Craig A. Barbarosh | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
From GuruFocus
By PRNewswire PRNewswire • 05-09-2023
By PRNewswire PRNewswire • 04-19-2023
By PRNewswire PRNewswire • 06-28-2022
By GuruFocus Research GuruFocus Editor • 08-17-2022
By PRNewswire PRNewswire • 06-30-2022
By PRNewswire • 08-24-2023
By PRNewswire PRNewswire • 01-31-2023
By PRNewswire PRNewswire • 04-17-2023
By PRNewswire • 12-06-2023
By PRNewswire PRNewswire • 03-03-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.